'''Dimemorfan''' ([[International Nonproprietary Name|INN]]) (or '''dimemorphan''') (brand names '''Astomin''', '''Dastosirr''', '''Tusben'''), or '''dimemorfan phosphate''' ([[Japanese Accepted Name|JAN]]), also known as '''3,17-dimethylmorphinan''', is an [[antitussive]] (cough suppressant) of the [[morphinan]] family that is widely used in [[Japan]] and is also marketed in [[Spain]] and [[Italy]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA427|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=427–}}</ref><ref name="BrueraHigginson2015">{{cite book|author1=Eduardo Bruera|author2=Irene Higginson|author3=Charles F. von Gunten|author4=Tatsuya Morita|title=Textbook of Palliative Medicine and Supportive Care, Second Edition|url=https://books.google.com/books?id=cdEgCAAAQBAJ&pg=PA677|date=15 January 2015|publisher=CRC Press|isbn=978-1-4441-3526-8|pages=677–}}</ref><ref name="Ida1997">{{cite journal|last1=Ida|first1=Hisashi|title=The nonnarcotic antitussive drug dimemorfan: a review|journal=Clinical Therapeutics|volume=19|issue=2|year=1997|pages=215–231|issn=0149-2918|doi=10.1016/S0149-2918(97)80111-7}}</ref><ref name="ArmstrongGoldman2005">{{cite book|author1=Lora L. Armstrong|author2=Morton P. Goldman|title=Lexi-Comp's Drug Information Handbook International: With Canadian and International Drug Monographs|url=https://books.google.com/books?id=twBtAAAAMAAJ|date=1 January 2005|publisher=Lexi-Comp|isbn=978-1-59195-110-0}}</ref> It was developed by [[Yamanouchi Pharmaceutical]] (now [[Astellas Pharma]]) and introduced in Japan in 1975.<ref name="Ida1997" /> Dimemorfan is an [[structural analog|analogue]] of [[dextromethorphan]] (DXM) and its [[active metabolite]] [[dextrorphan]] (DXO), and similarly to them, acts as a potent [[agonist]] of the [[sigma-1 receptor|σ<sub>1</sub> receptor]] (K<sub>i</sub> = 151 nM).<ref name="MauriceSu2009">{{cite journal|last1=Maurice|first1=Tangui|last2=Su|first2=Tsung-Ping|title=The pharmacology of sigma-1 receptors|journal=Pharmacology & Therapeutics|volume=124|issue=2|year=2009|pages=195–206|issn=0163-7258|doi=10.1016/j.pharmthera.2009.07.001}}</ref><ref name="BotanaLoza2012">{{cite book|author1=Luis M. Botana|author2=Mabel Loza|title=Therapeutic Targets: Modulation, Inhibition, and Activation|url=https://books.google.com/books?id=3XJ8PXFCXq4C&pg=PA234|date=20 April 2012|publisher=John Wiley & Sons|isbn=978-1-118-18552-0|pages=234–}}</ref> However, unlike DXM and DXO, it does not act significantly as an [[NMDA receptor antagonist]] (K<sub>i</sub> = 16,978&nbsp;nM), and for this reason, lacks [[dissociative]] effects, thereby having reduced [[side effect]]s and [[abuse potential]] in comparison.<ref name="ChouLiao1999">{{cite journal|last1=Chou|first1=Yueh-Ching|last2=Liao|first2=Jyh-Fei|last3=Chang|first3=Wan-Ya|last4=Lin|first4=Ming-Fang|last5=Chen|first5=Chieh-Fu|title=Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan|journal=Brain Research|volume=821|issue=2|year=1999|pages=516–519|issn=0006-8993|doi=10.1016/S0006-8993(99)01125-7|pmid=10064839}}</ref><ref name="ShinNah2005">{{cite journal|last1=Shin|first1=Eun-Joo|last2=Nah|first2=Seung-Yeol|last3=Kim|first3=Won-Ki|last4=Ko|first4=Kwang Ho|last5=Jhoo|first5=Wang-Kee|last6=Lim|first6=Yong-Kwang|last7=Cha|first7=Joo Young|last8=Chen|first8=Chieh-Fu|last9=Kim|first9=Hyoung-Chun|title=The dextromethorphan analog dimemorfan attenuates kainate-induced seizuresvia σ1receptor activation: comparison with the effects of dextromethorphan|journal=British Journal of Pharmacology|volume=144|issue=7|year=2005|pages=908–918|issn=0007-1188|doi=10.1038/sj.bjp.0705998|pmid=15723099|pmc=1576070}}</ref> Similarly to DXM and DXO, dimemorfan has only relatively low [[affinity (pharmacology)|affinity]] for the [[sigma-2 receptor|σ<sub>2</sub> receptor]] (K<sub>i</sub> = 4,421&nbsp;nM).<ref name="BotanaLoza2012" />
